Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

    NIH supports large-scale implementation research to improve adoption and reach of evidence-based HIV prevention, treatment, and care in U.S. communities significantly impacted by HIV.

    Browse similar grants
    Public Health Research Grants 2026Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

    Support research in implementing effective health interventions, especially in underrepresented communities, while also exploring the cessation of ineffective practices and improving research methods.

    HHS-NIH11Due Feb 5, 2027

    HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

    NIH funds milestone-driven research to develop, pilot, and expand testing of HIV prevention interventions, including approaches addressing alcohol use and related comorbidities.

    HHS-NIH11Forecasted Sep 7, 2027Forecasted

    Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

    Supports pilot and feasibility studies to prepare substance use and HIV intervention and services research trials, including prevention, treatment, and recovery research.

    HHS-NIH11Due Feb 16, 2027$450,000

    Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

    Supports high-risk, high-impact research on HIV and substance use to advance HIV prevention, diagnosis, treatment, and virus suppression among people who use substances or have substance use disorders.

    HHS-NIH11Due Sep 25, 2027$3,500,000

    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

    This grant supports innovative research at the HIV and substance use intersection, focusing on new avenues for prevention, treatment, and cure among people who use drugs.

    HHS-NIH11Due Feb 3, 2027$9,000,000